The usefulness of C-reactive protein as a biomarker in predicting neonatal sepsis in a sub-Saharan African region

Journal List BMC Res Notes v.13; 2020 PMC7110732 As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: PMC Disclaimer | PMC Copyright Notice BMC Res Notes. 2020; 13: 194. Published online 2020 Apr 1. doi:10.1186/s13104-020-05033-1PMCID: PMC7110732PMID: 32238170Gabriel Kambale Bunduki1,2 and Yaw Adu-Sarkodie2Author information Article notes Copyright and License information PMC DisclaimerAssociated DataData Availability StatementAbstractObjectiveThe early diagnosis of neonatal sepsis remains a challenge for physicians. The initiation or/and discontinuation of the empirical antibiotic therapy at neonates with sepsis is a dilemma due to the lack of definitive diagnosis and the fear of misdiagnosing a case with its serious outcomes, which can follow up. Therefore, this study aimed to assess the usefulness of C-reactive protein (CRP) as a...